Received May 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | — | — |
no additional AE; HCP called and reported inadvertent administration of a first dose of PROQUAD to a 13-year-old patient on 23MAY2025. Patient demographics not provided. No additional information was known by reporter at time of call. No additional AE/PQC.; This spontaneous report was received from a Physician and refers to a 13-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 23-MAY-2025, at the age of 13 years old, the patient was inadvertently vaccinated with the first dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), dose number 1, (dose, strength, route of administration, lot # and expiration date were not reported) for prophylaxis (product administered to patient of inappropriate age) together with sterile diluent (no details provided). No additional adverse event was reported (no adverse event). Lot # is being requested and will be submitted if received.
Sterile diluent